These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 33236691)

  • 41. EIF2B2 gene mutation causing early onset vanishing white matter disease: a case report.
    Filareto I; Cinelli G; Scalabrini I; Caramaschi E; Bergonzini P; Spezia E; Todeschini A; Iughetti L
    Ital J Pediatr; 2022 Jul; 48(1):128. PubMed ID: 35897042
    [TBL] [Abstract][Full Text] [Related]  

  • 42.
    Moon SL; Parker R
    RNA; 2018 Jun; 24(6):841-852. PubMed ID: 29632131
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Infantile onset Vanishing White Matter disease associated with a novel EIF2B5 variant, remarkably long life span, severe epilepsy, and hypopituitarism.
    Woody AL; Hsieh DT; McIver HK; Thomas LP; Rohena L
    Am J Med Genet A; 2015 Apr; 167A(4):826-30. PubMed ID: 25758335
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Energy Status of Astrocytes Is the Achilles' Heel of eIF2B-Leukodystrophy.
    Herrero M; Daw M; Atzmon A; Elroy-Stein O
    Cells; 2021 Jul; 10(8):. PubMed ID: 34440627
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Severity of vanishing white matter disease does not correlate with deficits in eIF2B activity or the integrity of eIF2B complexes.
    Liu R; van der Lei HD; Wang X; Wortham NC; Tang H; van Berkel CG; Mufunde TA; Huang W; van der Knaap MS; Scheper GC; Proud CG
    Hum Mutat; 2011 Sep; 32(9):1036-45. PubMed ID: 21560189
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Biochemical effects of mutations in the gene encoding the alpha subunit of eukaryotic initiation factor (eIF) 2B associated with Vanishing White Matter disease.
    Wortham NC; Proud CG
    BMC Med Genet; 2015 Aug; 16():64. PubMed ID: 26285592
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Subunits of the translation initiation factor eIF2B are mutant in leukoencephalopathy with vanishing white matter.
    Leegwater PA; Vermeulen G; Könst AA; Naidu S; Mulders J; Visser A; Kersbergen P; Mobach D; Fonds D; van Berkel CG; Lemmers RJ; Frants RR; Oudejans CB; Schutgens RB; Pronk JC; van der Knaap MS
    Nat Genet; 2001 Dec; 29(4):383-8. PubMed ID: 11704758
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mutations in each of the five subunits of translation initiation factor eIF2B can cause leukoencephalopathy with vanishing white matter.
    van der Knaap MS; Leegwater PA; Könst AA; Visser A; Naidu S; Oudejans CB; Schutgens RB; Pronk JC
    Ann Neurol; 2002 Feb; 51(2):264-70. PubMed ID: 11835386
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Regulation of protein synthesis in lymphoblasts from vanishing white matter patients.
    van Kollenburg B; Thomas AA; Vermeulen G; Bertrand GA; van Berkel CG; Pronk JC; Proud CG; van der Knaap MS; Scheper GC
    Neurobiol Dis; 2006 Mar; 21(3):496-504. PubMed ID: 16185887
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Secretomics Alterations and Astrocyte Dysfunction in Human iPSC of Leukoencephalopathy with Vanishing White Matter.
    Deng J; Zhang J; Gao K; Yan W; Zhou L; Jiang Y; Wang J; Wu Y
    Neurochem Res; 2022 Dec; 47(12):3747-3760. PubMed ID: 36198922
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A point mutation in translation initiation factor eIF2B leads to function--and time-specific changes in brain gene expression.
    Marom L; Ulitsky I; Cabilly Y; Shamir R; Elroy-Stein O
    PLoS One; 2011; 6(10):e26992. PubMed ID: 22073122
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Adult-onset leukoencephalopathy with vanishing white matter with compound heterozygous EIF2B3 gene variants.
    Gui M; He M; Qin L
    BMC Neurol; 2024 Jun; 24(1):201. PubMed ID: 38872124
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Therapeutic potential of human stem cell transplantations for Vanishing White Matter: A quest for the Goldilocks graft.
    Hillen AEJ; Leferink PS; Breeuwsma NB; Dooves S; Bergaglio T; Van der Knaap MS; Heine VM
    CNS Neurosci Ther; 2022 Sep; 28(9):1315-1325. PubMed ID: 35778846
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Adult-onset vanishing white matter in a patient with EIF2B3 variants misdiagnosed as multiple sclerosis.
    Xu L; Zhong M; Yang Y; Wang M; An N; Xu X; Zhu Y; Li Z; Chen H; Zhao R; Zheng X
    Neurol Sci; 2022 Apr; 43(4):2659-2667. PubMed ID: 34755279
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Drug Screening Identifies Sigma-1-Receptor as a Target for the Therapy of VWM Leukodystrophy.
    Atzmon A; Herrero M; Sharet-Eshed R; Gilad Y; Senderowitz H; Elroy-Stein O
    Front Mol Neurosci; 2018; 11():336. PubMed ID: 30279648
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Modeling vanishing white matter disease with patient-derived induced pluripotent stem cells reveals astrocytic dysfunction.
    Zhou L; Li P; Chen N; Dai LF; Gao K; Liu YN; Shen L; Wang JM; Jiang YW; Wu Y
    CNS Neurosci Ther; 2019 Jun; 25(6):759-771. PubMed ID: 30720246
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A case of ovarioleukodystrophy without eIF2B mutations.
    Gaudiano C; Di Perri C; Scali O; Rufa A; Battisti C; De Stefano N; Federico A
    J Neurol Sci; 2008 May; 268(1-2):183-6. PubMed ID: 18061208
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Vanishing white matter disease: imaging, clinical and molecular correlation in Brazilian families.
    Albacete MAP; Simão GN; Lourenço CM; Dos Santos AC
    Neuroradiology; 2024 Sep; 66(9):1553-1564. PubMed ID: 38886214
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Eif2b3 mutants recapitulate phenotypes of vanishing white matter disease and validate novel disease alleles in zebrafish.
    Lee YR; Kim SH; Ben-Mahmoud A; Kim OH; Choi TI; Lee KH; Ku B; Eum J; Kee Y; Lee S; Cha J; Won D; Lee ST; Choi JR; Lee JS; Kim HD; Kim HG; Bonkowsky JL; Kang HC; Kim CH
    Hum Mol Genet; 2021 Apr; 30(5):331-342. PubMed ID: 33517449
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [CACH/VWM syndrome and leucodystrophies related to EIF2B mutations].
    Labauge P; Fogli A; Niel F; Rodriguez D; Boespflug-Tanguy O
    Rev Neurol (Paris); 2007 Sep; 163(8-9):793-9. PubMed ID: 17878805
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.